Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.

Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...

AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

As AI evolves to enterprise-grade complexity and scale, a new operating model is quietly evolving - Agentic Process Outsourcing. Here is how.

MIDDLETOWN, DE, UNITED STATES, February 16, 2026 /EINPresswire.com/ -- Async, recently rebranded from Podcastle, today ...

Most API vulnerabilities are fast, remote, and easy to exploit. Attackers take full advantage of these attributes.

AbbVie (NYSE: ABBV) today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at its current North Chicago, Illinois, campus. These ...

The pharmaceutical manufacturing market is poised for growth by leveraging advanced technologies, digital platforms, and robust supply chain strategies. Opportunities arise in adopting ...

As organisations accelerate digital onboarding and automated compliance processes, the security and reliability of verification APIs are coming under increased scrutiny. For development teams, the ...